Rapid Nutrition, CEO Simon St. Ledger joined Steve Darling from Proactive Vancouver with news the company has launched a new oral anti-viral treatment called Azurene that is designed to combat influenza and the common cold in humans.

St Ledger telling Proactive this anti-viral formula relates to the use of a combination of herbal extracts to provide a broad spectrum of protection, treatment and relief from acute respiratory viral infections, including, influenza, SARS, coronavirus and even the common cold.

Attachments

  • Original document
  • Permalink

Disclaimer

Rapid Nutrition plc published this content on 07 May 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 May 2020 02:28:00 UTC